X4 Pharmaceuticals Inc Revenue per Employee (XFOR), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
X4 Pharmaceuticals Inc  (NASDAQ: XFOR)
 

X4 Pharmaceuticals Inc's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 58.64% in the third quarter 2026, year on year to cumulative value of $10 million, X4 Pharmaceuticals Inc's revenue per employee grew on a trailing twelve months basis to $ 232,800, this is below the company average.
Within the Healthcare sector Employees of 395 other companies have achieved higher revenue per employee. While X4 Pharmaceuticals Inc's total ranking has deteriorated compared to the previous quarter from 1875 to 3016. X4 Pharmaceuticals Inc has 45 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

XFOR Revenue per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Revenue Change 58.64 % 21.64 % -90.6 % 79.08 % 215.18 %
Sales per Employee (TTM) $ 232,800 209,800 200,311 780,289 755,089
XFOR's Total Ranking # 3016 # 1875 # 1028 # 465 #
Seq. Revenue Change 16.67 % -11.37 % 5.45 % 45.5 % -10.54 %

XFOR Company Profile >> Back to XFOR Efficiency Comparisons >> Compare XFOR Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 47
Healthcare Sector # 396
Overall Market # 3016

Revenue per Employee Statistics
High Average Low
$ 780,289 $ 632,196 $ 200,311
(Dec 31 2025)   (Mar 31 2026)



Financial Statements
X4 Pharmaceuticals Inc's Revenue MRQ $ 3 Millions Visit XFOR's Income Statement
X4 Pharmaceuticals Inc's Revenues TTM $ 10 Millions Visit XFOR's aggregate revenue growth
What are XFOR's Sales? Visit XFOR's Sales by Segment




Other Ratios
X4 Pharmaceuticals Inc's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
XFOR's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for XFOR's Competitors
Revenue per Employee for XFOR's Suppliers
Revenue per Employee for XFOR's Customers

You may also want to know
XFOR's Sales Growth Rates XFOR's Pe Price to earnings ratio XFOR's Receivables Turnover Ratio XFOR's Stock Quote
XFOR's Net Income Growth Rates XFOR's Ps Price to Sales ratio XFOR's Sales per Employee XFOR's Asset Turnover Ratio
XFOR's Net Margin XFOR's Pb Price to Book ratio XFOR's Financial Strength Ratios XFOR's Dividend Payout Ratio
Date modified: 2026-11-06T12:59:09+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Innovage Holding Corp   407,343.60 $ 1,018.359  Million 2,500 
Brightspring Health Services Inc   403,367.83 $ 9,479.144  Million 23,500 
Repligen Corp  402,805.00 $ 805.610  Million 2,000 
Strata Critical Medical Inc   393,386.02 $ 236.425  Million 601 
Iovance Biotherapeutics inc   388,700.51 $ 378.983  Million 975 
Pro dex Inc   386,300.97 $ 79.578  Million 206 
Edap Tms Sa  385,363.32 $ 111.370  Million 289 
Msa Safety Inc  380,326.42 $ 2,015.730  Million 5,300 
Mimedx Group Inc   375,449.26 $ 303.363  Million 808 
Avita Medical Inc   374,703.54 $ 84.683  Million 226 
Integra Lifesciences Holdings Corp  374,245.76 $ 1,656.786  Million 4,427 
Ge Healthcare Technologies Inc   368,111.11 $ 19,878.000  Million 54,000 
Boston Scientific Corporation  357,118.64 $ 21,070.000  Million 59,000 
Conmed Corporation  351,099.49 $ 1,369.288  Million 3,900 
Bio rad Laboratories Inc   348,053.69 $ 2,593.000  Million 7,450 
Neogen Corporation  335,402.12 $ 884.120  Million 2,636 
Ceribell Inc   333,954.13 $ 109.203  Million 327 
Aquestive Therapeutics Inc   332,224.49 $ 48.837  Million 147 
Penumbra Inc  331,985.96 $ 1,560.334  Million 4,700 
Tactile Systems Technology Inc   328,891.34 $ 357.176  Million 1,086 
Bruker Corporation  316,869.64 $ 3,512.500  Million 11,085 
Biodesix Inc   315,005.99 $ 105.212  Million 334 
West Pharmaceutical Services Inc   314,546.30 $ 3,397.100  Million 10,800 
Baxter International Inc   314,240.00 $ 11,784.000  Million 37,500 
Beta Bionics Inc   304,521.43 $ 127.899  Million 420 
Pulmonx Corporation  301,270.27 $ 89.176  Million 296 
Pediatrix Medical Group Inc   298,874.75 $ 1,959.124  Million 6,555 
Bicycle Therapeutics Plc  290,027.78 $ 83.528  Million 288 
Adapthealth Corp   289,178.26 $ 3,152.043  Million 10,900 
Beam Therapeutics Inc   286,974.56 $ 146.644  Million 511 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.